TUB-030

· Tubulis GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TUB-030, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of TUB-030 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]